Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab

Aim. To study the characteristics of direct oral anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease (COPD) and atrial fibrillation. To show the efficacy of idarucizumab in complex therapy of severe gastrointestinal bleeding caused...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	L. A. Shpagina, O. S. Kotova, I. S. Shpagin, E. M. Loktin, A. A. Rukavitsyna, T. S. Flyagin, T. M. Smarzh, N. V. Kamneva, D. A. Gerasimenko, E. V. Anikina, A. V. Ponomareva
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	«FIRMA «SILICEA» LLC 2020-06-01
Saila:	Российский кардиологический журнал
Gaiak:	direct oral anticoagulants bleeding idarucizumab
Sarrera elektronikoa:	https://russjcardiol.elpub.ru/jour/article/view/3921
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!